| 152 |
Penicillin
|
|
None
|
| 153 |
Vinyl acetate
|
-
Vinyl acetate, CAS-RN: 108-05-4, DTXSID3021431
|
136: Intracellular Acidification Induced Olfactory Epithelial Injury Leading to Site of Contact Nasal Tumors
|
| 154 |
Ethyl acetate
|
-
Ethyl acetate, CAS-RN: 141-78-6, DTXSID1022001
|
None
|
| 155 |
Propyl Acetate
|
-
Propyl acetate, CAS-RN: 109-60-4, DTXSID6021901
|
None
|
| 156 |
Aspartame
|
-
Aspartame, CAS-RN: 22839-47-0, DTXSID0020107
|
None
|
| 157 |
Gabapentin
|
-
Gabapentin, CAS-RN: 60142-96-3, DTXSID0020074
|
None
|
| 158 |
Indole
|
-
Indole, CAS-RN: 120-72-9, DTXSID0020737
|
None
|
| 159 |
dibenzofuran
|
-
Dibenzofuran, CAS-RN: 132-64-9, DTXSID2021993
|
None
|
| 160 |
Halogenated phenols
|
|
152: Interference with thyroid serum binding protein transthyretin and subsequent adverse human neurodevelopmental toxicity
|
| 161 |
Levothyroxine
|
-
Levothyroxine, CAS-RN: 51-48-9, DTXSID8023214
|
None
|
| 162 |
1,2,4-triazole
|
|
153: Aromatase Inhibition leading to Ovulation Inhibition and Decreased Fertility in Female Rats
|
| 163 |
Tacrolimus (also FK506)
|
-
Tacrolimus, CAS-RN: 104987-11-3, DTXSID5046354
|
2 AOPs
|
| 164 |
Tebufenozide
|
-
Tebufenozide, CAS-RN: 112410-23-8, DTXSID4034948
|
2 AOPs
|
| 165 |
Benzoic acid, 3-methoxy-2-methyl-, 2-(3,5-dimethylbenzoyl)-2-(1,1-dimethylethyl)hydrazide
|
|
None
|
| 166 |
Benzoic acid, 4-chloro-, 2-benzoyl-2-(1,1-dimethylethyl)hydrazide
|
|
None
|
| 167 |
1',2'-dihydrorotenone
|
-
1',2'-Dihydrorotenone, CAS-RN: 6659-45-6, DTXSID5041227
|
None
|
| 168 |
2-Imidazolidinimine, 1-[(6-chloro-3-pyridinyl)methyl]-N-nitro-, (2E)-
|
|
None
|
| 169 |
Sunitinib malate Sunitinib (INN)
|
|
43: Disruption of VEGFR Signaling Leading to Developmental Defects
|
| 170 |
thiazopyr
|
-
Thiazopyr, CAS-RN: 117718-60-2, DTXSID1032488
|
162: Enhanced hepatic clearance of thyroid hormones leading to thyroid follicular cell adenomas and carcinomas in the rat and mouse
|
| 171 |
Pyrethrins and Pyrethroids
|
|
3 AOPs
|
| 172 |
Tamoxifen
|
-
Tamoxifen, CAS-RN: 10540-29-1, DTXSID1034187
|
3 AOPs
|
| 173 |
Raloxifene
|
-
Raloxifene, CAS-RN: 84449-90-1, DTXSID3023550
|
2 AOPs
|
| 174 |
Fulvestrant
|
-
Fulvestrant, CAS-RN: 129453-61-8, DTXSID4022369
|
165: Antiestrogen activity leading to ovarian adenomas and granular cell tumors in the mouse
|
| 175 |
PERFLUOROOCTANOIC ACID
|
|
2 AOPs
|
| 176 |
Diethylstilbestrol
|
-
Diethylstilbestrol, CAS-RN: 56-53-1, DTXSID3020465
|
167: Early-life estrogen receptor agonism leading to endometrial adenosquamous carcinoma via promotion of sine oculis homeobox 1 progenitor cells
|